All News

Global confirmed cases of COVID-19 have surpassed 45 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Compared with never smokers, current smokers face nearly 3-times the risk of premature death from heart disease or stroke, according to a new study.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Patrick Moriarty, MD, from the University of Kansas Medical Center, discusses the role of Lp(a) as a risk factor for cardiovascular disease and the phase 3 trials of a potential treatment.

Rapidly rising obesity rates in the US threaten to reverse decades of effort against cardiometabolic disease. How well do you know what experts recommend for your at-risk patients?

Carl "Chip" Lavie, MD, author of the original book titled, "The Obesity Paradox" explains the paradox of metabolic health in the obese, how it wanes, and an essential element to maintain it.

For the first time, the USPSTF recommends colorectal cancer screening in adults beginning at age 45.

Waist circumference measures, complementary antihypertensives, appropriate exercise levels for T2D patients--test what you know about cardiometabolic risk and management.

Global confirmed cases of COVID-19 have surpassed 44 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Weight loss is essential to arrest the cardiovascular disease and metabolic dysfunction linked to obesity. What do you know about the drugs now available that may help?

How many cases of COVID-19 have been confirmed in the US? How many people have been tested? Get your daily COVID-19 update here.

Dapagliflozin is renoprotective and cardioprotective in chronic kidney disease patients, suggests a secondary analysis of the DAPA-CKD trial presented at Kidney Week 2020.

Confirmed cases of COVID-19 surged in these 5 states, global cases topped 43 million, and more COVID-19 data to know about today, October 26, 2020.

Reduced risk of mortality as well as of ICU admission and mechanical ventilation were observed in patients with COVID-19 taking daily aspirin for CV prevention.

The FDA has approved remdesivir for the treatment of COVID-19, making it the first approved treatment for the novel disease.

The investigational mineralocorticoid receptor antagonist slowed progression to renal failure by 18% and reduced the composite cardiovascular outcome by 14%, authors report.

The first study to compare COVID-19 and influenza complications in hospitalized patients found COVID-19 patients more likely to be admitted to ICU and to die.

A recent survey assessed American’s acceptance of 11 false COVID-19 claims circulating online. What were the results? Take our 7-question quiz to find out.